BioAtla (BCAB) Equity Average (2020 - 2025)
BioAtla's Equity Average history spans 6 years, with the latest figure at -$33.7 million for Q4 2025.
- For Q4 2025, Equity Average fell 281.09% year-over-year to -$33.7 million; the TTM value through Dec 2025 reached -$33.7 million, down 281.09%, while the annual FY2025 figure was -$11.0 million, 125.81% down from the prior year.
- Equity Average reached -$33.7 million in Q4 2025 per BCAB's latest filing, down from -$24.0 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $220.7 million in Q4 2021 to a low of -$33.7 million in Q4 2025.
- Average Equity Average over 5 years is $104.9 million, with a median of $125.0 million recorded in 2023.
- Peak YoY movement for Equity Average: skyrocketed 407.89% in 2021, then crashed 281.09% in 2025.
- A 5-year view of Equity Average shows it stood at $220.7 million in 2021, then fell by 26.84% to $161.5 million in 2022, then tumbled by 48.8% to $82.7 million in 2023, then plummeted by 77.49% to $18.6 million in 2024, then plummeted by 281.09% to -$33.7 million in 2025.
- Per Business Quant, the three most recent readings for BCAB's Equity Average are -$33.7 million (Q4 2025), -$24.0 million (Q3 2025), and -$8.1 million (Q2 2025).